FOS and Autoimmunity: These results indicate that the NF-κB, NF-AT, and AP‐1 (c-Fos) signaling pathways are involved in the T cell inhibition evoked by saikosaponins, demonstrating their potential for treating T cell-mediated autoimmune conditions [123].